Skip to main content
. 2020 May 8;26:e923517-1–e923517-15. doi: 10.12659/MSM.923517

Figure 7.

Figure 7

Prognostic values of FGFR2 in breast cancer subgroups. Kaplan-Meier plot demonstrated the RFS of FGFR2 in patients with different clinical characteristics including (A) ER-positive breast cancer, (B) PR-positive breast cancer, (C) HER2-positive breast cancer, (D) basal subtype, (E) luminal B subtype, (F) luminal A subtype, (G) lymph node positive status, and (H) lymph node negative status. FGFR2 – fibroblast growth factor receptors 2; RFS – relapse-free survival; ER – estrogen receptor; PR – progesterone receptor; HER2 – human epidermal growth factor receptor 2.